Hindustan Bio Sciences Ltd.

HINDBIO

₹9.35

3.89% (0.35)

Market Cap

₹10 Cr.

P/E

94.90

Key Ratios

Edit Ratio's

Market cap

10.00 Cr

94.90

Prom Holding

12.19 %

ROE (%)

7.16

ROCE (%)

1.70

Div Yield (%)

Sales

0.79 Cr

OPM (%)

9.29 %

Debt to Equity

3.18

Edit Ratio's

About

Hindustan Bio Sciences Limited is engaged in the manufacturing and sale of pharmaceutical prod… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

3 No Data

Insufficient data to analyse

Accounting & Shareholding

Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Contingent Liabilities

Unable to calculate due to limited data
Other Income

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Share price

Share price has increased over last 10 years but more due to rerating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Hindustan Bio Sciences Ltd. Business

What does Hind Bio Science do?

Hindustan Bio Sciences Limited is a public limited company established in 1991, specializing in the manufacturing and sale of pharmaceutical products.

Who are the competitors of Hind Bio Science?

Hind Bio Science major competitors are Unjha Formulations, Cian Healthcare, Ortin Global, Secunderabad Health., Senbo Industries, Beryl Drugs, Colinz Laboratories.
Market Cap of Hind Bio Science is ₹9 Crs.
While the median market cap of its peers are ₹10 Crs.

Is Hind Bio Science financially stable compared to its competitors?

Hind Bio Science seems to be less financially stable compared to its competitors.
Altman Z score of Hind Bio Science is 0 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Hindustan Bio Sciences Ltd.

Hindustan Bio Sciences Ltd.

Key Ratios

About

Timeline

Company Timeline

8 Yes

2 Neutral

4 No

3 No Data

Accounting & Shareholding

Pledge

Retail Holding

Revenue Recognition

Depreciation Effect

Promoter Holding

Contingent Liabilities

Other Income

Price & Performance

Capex vs ROCE

ROE

Working Capital

Debt

Balance Sheet Strength

Share price

Sales Growth

Margin Stability

ROCE Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does Hind Bio Science do?

Who are the competitors of Hind Bio Science?

Is Hind Bio Science financially stable compared to its competitors?

SIGN UP FOR FREE